Interestingly, low LRP2 expression was associated with tumor cell dedifferentiation and poor outcome in clear cell renal cell carcinoma, papillary renal cell carcinoma, mesothelioma, papillary thyroid carcinoma, and invasive breast carcinoma. Here, LRP2 is linked to differentiated thyroid carcinoma.